Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD123 ( clone 28626). We employs the pUC (pBAD-RFP-PAX-EcoRI) vector components and the SynExpress system of the introns Substitution/Negative feedback for a robust and sustained response against cancers.
Host
human
Target
CD123
Clone
28626
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
pBAD
Effector Gene
PAX
Insertion Sites
EcoRI
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
pUC
Transformation Accuracy
0.87
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.